Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/110383
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sanmartí Sala, Raimon | - |
dc.contributor.author | Inciarte-Mundo, Jose | - |
dc.contributor.author | Estrada-Alarcon, Paula | - |
dc.contributor.author | Garcia-Manrique, Maria | - |
dc.contributor.author | Narváez García, Francisco Javier | - |
dc.contributor.author | Rodríguez Moreno, Jesús | - |
dc.contributor.author | Gomez-Centeno, Antoni | - |
dc.contributor.author | Pascal i Capdevila, Mariona | - |
dc.contributor.author | Yagüe, Jordi | - |
dc.date.accessioned | 2017-05-03T10:54:53Z | - |
dc.date.available | 2017-05-03T10:54:53Z | - |
dc.date.issued | 2015-08 | - |
dc.identifier.issn | 0003-4967 | - |
dc.identifier.uri | http://hdl.handle.net/2445/110383 | - |
dc.description | Article en format correspondència | - |
dc.description.abstract | We read with great interest the paper by Chen et al1 analysing the relationship between therapeutic response to adalimumab and etanercept and serum drug trough levels in 70 patients with rheumatoid arthritis (RA). ... | - |
dc.format.extent | 1 p. | - |
dc.format.mimetype | application/pdf | - |
dc.language.iso | eng | - |
dc.publisher | BMJ Publishing Group | - |
dc.relation.isformatof | Reproducció del document publicat a: https://doi.org/10.1136/annrheumdis-2015-207530 | - |
dc.relation.ispartof | Annals of the Rheumatic Diseases, 2015, vol. 74, num. 8, p. e42 | - |
dc.relation.uri | https://doi.org/10.1136/annrheumdis-2015-207530 | - |
dc.rights | (c) BMJ Publishing Group, 2015 | - |
dc.source | Articles publicats en revistes (Ciències Clíniques) | - |
dc.subject.classification | Artritis reumatoide | - |
dc.subject.classification | Medicaments | - |
dc.subject.classification | Administració de medicaments | - |
dc.subject.classification | Sistema immunològic | - |
dc.subject.classification | Anticossos monoclonals | - |
dc.subject.other | Rheumatoid arthritis | - |
dc.subject.other | Drugs | - |
dc.subject.other | Administration of drugs | - |
dc.subject.other | Immune system | - |
dc.subject.other | Monoclonal antibodies | - |
dc.title | Towards optimal cut-off trough levels of adalimumab and etanercept for a good therapeutic response in rheumatoid arthritis. Results of the INMUNOREMAR study | - |
dc.type | info:eu-repo/semantics/article | - |
dc.type | info:eu-repo/semantics/publishedVersion | - |
dc.identifier.idgrec | 657895 | - |
dc.date.updated | 2017-05-03T10:54:54Z | - |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | - |
Appears in Collections: | Articles publicats en revistes (Ciències Clíniques) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
657895.pdf | 411.63 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.